A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)

An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata

A phase 2 study to find out if the drug ruxolitinib Phosphate Cream is safe and has beneficial effects in people who have alopecia areata (partial or complete hair loss) when applied to the skin.

Inclusion Criteria:

• Diagnosis of AA
• Duration and extent of current episode of AA
• Evidence of active hair loss

Exclusion Criteria:

• Evidence of diffuse, spontaneous terminal hair regrowth
• Receipt of treatment known to potentially affect the course of AA within last month